Analysts: Monsanto Co (MON.N)
MON.N on New York Stock Exchange
105.89USD
4:03pm EDT
105.89USD
4:03pm EDT
Price Change (% chg)
$0.26 (+0.25%)
$0.26 (+0.25%)
Prev Close
$105.63
$105.63
Open
$105.62
$105.62
Day's High
$106.28
$106.28
Day's Low
$105.13
$105.13
Volume
471,308
471,308
Avg. Vol
638,076
638,076
52-wk High
$109.33
$109.33
52-wk Low
$76.90
$76.90
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.37 | August | 19 Jun 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 8 | 8 | 9 |
| (2) OUTPERFORM | 10 | 9 | 9 | 8 |
| (3) HOLD | 5 | 6 | 6 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.04 | 2.04 | 1.91 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Aug-13 | 16 | 2,218.89 | 2,434.00 | 1,994.00 | 2,323.45 |
| Quarter Ending Nov-13 | 5 | 3,147.60 | 3,296.66 | 2,995.30 | 2,876.95 |
| Year Ending Aug-13 | 21 | 15,121.30 | 15,720.00 | 14,599.00 | 14,326.40 |
| Year Ending Aug-14 | 21 | 16,183.70 | 17,268.60 | 15,031.00 | 15,074.10 |
| Earnings (per share) | |||||
| Quarter Ending Aug-13 | 19 | -0.37 | -0.16 | -0.50 | -0.17 |
| Quarter Ending Nov-13 | 6 | 0.67 | 0.79 | 0.59 | 0.42 |
| Year Ending Aug-13 | 24 | 4.60 | 5.00 | 4.50 | 4.22 |
| Year Ending Aug-14 | 26 | 5.29 | 5.60 | 4.69 | 4.80 |
| LT Growth Rate (%) | 7 | 12.90 | 19.00 | 8.00 | 11.53 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Feb-13 | 5,270.65 | 5,472.00 | 201.35 | 3.82 |
| Quarter Ending Nov-12 | 2,640.23 | 2,939.00 | 298.77 | 11.32 |
| Quarter Ending Aug-12 | 2,251.91 | 2,110.00 | 141.91 | 6.30 |
| Quarter Ending May-12 | 3,995.91 | 4,219.00 | 223.09 | 5.58 |
| Quarter Ending Feb-12 | 4,530.20 | 4,748.00 | 217.80 | 4.81 |
| Earnings (per share) | ||||
| Quarter Ending Feb-13 | 2.58 | 2.73 | 0.15 | 5.75 |
| Quarter Ending Nov-12 | 0.37 | 0.62 | 0.25 | 67.98 |
| Quarter Ending Aug-12 | -0.42 | -0.44 | 0.02 | -3.95 |
| Quarter Ending May-12 | 1.60 | 1.63 | 0.03 | 1.84 |
| Quarter Ending Feb-12 | 2.12 | 2.28 | 0.16 | 7.77 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Aug-13 | 2,218.89 | 2,214.20 | 2,199.01 | 2,199.01 | 2,323.45 |
| Quarter Ending Nov-13 | 3,147.60 | 3,147.60 | 3,126.56 | 3,126.56 | 2,876.95 |
| Year Ending Aug-13 | 15,121.30 | 15,125.90 | 15,148.70 | 15,148.70 | 14,326.40 |
| Year Ending Aug-14 | 16,183.70 | 16,189.10 | 16,193.10 | 16,193.10 | 15,074.10 |
| Earnings (per share) | |||||
| Quarter Ending Aug-13 | -0.37 | -0.37 | -0.40 | -0.40 | -0.17 |
| Quarter Ending Nov-13 | 0.67 | 0.67 | 0.63 | 0.63 | 0.42 |
| Quarter Ending Aug-13 | 4.60 | 4.59 | 4.61 | 4.61 | 4.22 |
| Quarter Ending Aug-14 | 5.29 | 5.29 | 5.29 | 5.29 | 4.80 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Aug-13 | 1 | 0 | 6 | 2 |
| Quarter Ending Nov-13 | 0 | 0 | 1 | 2 |
| Year Ending Aug-13 | 0 | 1 | 5 | 6 |
| Year Ending Aug-14 | 0 | 1 | 3 | 7 |
| Earnings | ||||
| Quarter Ending Aug-13 | 0 | 0 | 10 | 3 |
| Quarter Ending Nov-13 | 0 | 0 | 4 | 0 |
| Year Ending Aug-13 | 1 | 0 | 5 | 8 |
| Year Ending Aug-14 | 0 | 0 | 6 | 5 |
- Monsanto exec, other biotech pioneers win World Food Prize
- Fitch Affirms Monsanto's IDRs at 'A+/F1'; Outlook Stable
- Organic growers lose decision in suit versus Monsanto over seeds
- UPDATE 1-Organic growers lose decision in suit vs. Monsanto over seeds
- Organic growers lose decision in suit vs. Monsanto over seeds
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (MON). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates